| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
132,680 |
120,528 |
$11.05M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
61,683 |
53,026 |
$4.22M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,082 |
20,911 |
$1.73M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,097 |
8,189 |
$1.24M |
| 80053 |
Comprehensive metabolic panel |
53,414 |
44,695 |
$1.21M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,405 |
7,206 |
$735K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,734 |
5,392 |
$584K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,266 |
6,075 |
$340K |
| 87070 |
|
16,666 |
16,141 |
$292K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,542 |
2,233 |
$256K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,232 |
8,898 |
$247K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,331 |
3,217 |
$242K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,206 |
2,828 |
$239K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,038 |
876 |
$216K |
| 81001 |
|
47,692 |
41,846 |
$187K |
| 80306 |
|
9,930 |
8,642 |
$165K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
35,756 |
28,097 |
$157K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,029 |
2,572 |
$150K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,108 |
2,752 |
$134K |
| 87430 |
|
31,156 |
29,935 |
$126K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,778 |
16,112 |
$122K |
| G0378 |
Hospital observation service, per hour |
8,129 |
4,189 |
$110K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,880 |
1,599 |
$110K |
| 87275 |
|
9,565 |
8,895 |
$102K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,921 |
2,251 |
$101K |
| 80047 |
|
3,708 |
3,298 |
$100K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
7,798 |
7,205 |
$95K |
| 71045 |
Radiologic examination, chest; single view |
29,438 |
25,636 |
$93K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,990 |
677 |
$93K |
| 71046 |
Radiologic examination, chest; 2 views |
13,929 |
12,770 |
$92K |
| 81025 |
|
37,089 |
33,601 |
$83K |
| 85027 |
|
71,090 |
56,386 |
$79K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,936 |
7,874 |
$75K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
36,255 |
30,837 |
$74K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,236 |
2,262 |
$71K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,881 |
3,758 |
$67K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36,808 |
35,212 |
$62K |
| A9270 |
Non-covered item or service |
15,011 |
4,824 |
$55K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13,320 |
12,493 |
$54K |
| 73610 |
|
2,288 |
2,144 |
$48K |
| 70491 |
|
262 |
248 |
$48K |
| 84702 |
|
7,307 |
5,917 |
$47K |
| 73130 |
|
2,362 |
2,196 |
$47K |
| 81003 |
|
13,183 |
11,668 |
$46K |
| 12001 |
|
793 |
752 |
$45K |
| 72131 |
|
1,469 |
1,274 |
$44K |
| 73630 |
|
2,851 |
2,628 |
$41K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,520 |
1,215 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,856 |
7,320 |
$40K |
| 73564 |
|
2,359 |
2,144 |
$39K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,703 |
2,494 |
$39K |
| 00840 |
|
265 |
248 |
$37K |
| 73030 |
|
2,381 |
2,121 |
$37K |
| 12011 |
|
489 |
454 |
$35K |
| 76801 |
|
3,282 |
2,620 |
$34K |
| 10060 |
|
772 |
733 |
$34K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,325 |
3,452 |
$32K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,246 |
2,288 |
$31K |
| 59025 |
Fetal non-stress test |
1,435 |
1,151 |
$31K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
102 |
44 |
$31K |
| 70486 |
|
754 |
674 |
$29K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,317 |
12,738 |
$29K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
25,588 |
21,081 |
$28K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
794 |
742 |
$27K |
| 73110 |
|
1,388 |
1,292 |
$27K |
| 93976 |
|
2,081 |
1,845 |
$27K |
| 87252 |
|
824 |
795 |
$26K |
| 76830 |
Ultrasound, transvaginal |
1,504 |
1,376 |
$26K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,529 |
1,375 |
$25K |
| 71250 |
|
331 |
283 |
$24K |
| C1769 |
Guide wire |
553 |
468 |
$24K |
| 74018 |
|
1,656 |
1,547 |
$24K |
| 87490 |
|
10,317 |
9,558 |
$21K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
6,436 |
5,837 |
$19K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
149 |
138 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
274 |
215 |
$19K |
| 72100 |
|
1,377 |
1,258 |
$18K |
| 93971 |
|
1,631 |
1,466 |
$18K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,013 |
2,303 |
$17K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12,721 |
10,725 |
$17K |
| 84484 |
|
27,216 |
20,027 |
$17K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,032 |
5,290 |
$16K |
| 96376 |
|
1,678 |
1,348 |
$15K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
95 |
74 |
$15K |
| 93017 |
|
1,105 |
938 |
$15K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
762 |
623 |
$15K |
| 73140 |
|
680 |
649 |
$15K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,645 |
14,027 |
$14K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,943 |
1,237 |
$14K |
| 85610 |
|
13,710 |
11,346 |
$13K |
| 73080 |
|
584 |
549 |
$12K |
| 97163 |
|
173 |
154 |
$10K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
76 |
68 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,292 |
10,881 |
$10K |
| 86850 |
|
1,876 |
1,560 |
$9K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
786 |
724 |
$8K |
| 82565 |
|
411 |
345 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,078 |
5,973 |
$8K |
| 73502 |
|
768 |
674 |
$7K |
| 83735 |
|
18,093 |
15,180 |
$7K |
| 73590 |
|
745 |
673 |
$7K |
| 87590 |
|
10,313 |
9,554 |
$6K |
| 83880 |
|
5,685 |
4,834 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20,874 |
19,989 |
$6K |
| 93970 |
|
491 |
425 |
$6K |
| 85730 |
|
11,849 |
9,959 |
$6K |
| 84703 |
|
3,702 |
3,334 |
$6K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
145 |
102 |
$6K |
| 97535 |
Self-care/home management training, each 15 minutes |
213 |
140 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,071 |
898 |
$5K |
| 87807 |
|
5,682 |
5,525 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,867 |
1,499 |
$5K |
| 12002 |
|
164 |
150 |
$5K |
| 83690 |
|
17,659 |
15,178 |
$5K |
| 86140 |
|
1,116 |
965 |
$4K |
| 70496 |
|
127 |
115 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
167 |
151 |
$4K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
909 |
720 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
297 |
245 |
$4K |
| 72192 |
|
85 |
65 |
$4K |
| 73552 |
|
250 |
236 |
$4K |
| 73562 |
|
460 |
426 |
$3K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,038 |
877 |
$3K |
| 85379 |
|
3,285 |
2,987 |
$3K |
| 86901 |
|
3,249 |
2,777 |
$3K |
| 73560 |
|
100 |
86 |
$3K |
| J3490 |
Unclassified drugs |
784 |
663 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,861 |
1,579 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,910 |
1,660 |
$3K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
336 |
278 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,696 |
2,296 |
$2K |
| 87040 |
|
5,278 |
4,201 |
$2K |
| 16020 |
|
20 |
13 |
$2K |
| 86308 |
|
310 |
302 |
$2K |
| 86900 |
|
1,873 |
1,558 |
$2K |
| 80061 |
Lipid panel |
1,742 |
1,464 |
$2K |
| 73090 |
|
360 |
337 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,239 |
1,884 |
$2K |
| 87276 |
|
9,569 |
8,893 |
$2K |
| 73620 |
|
121 |
112 |
$2K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
126 |
106 |
$2K |
| 72050 |
|
59 |
50 |
$2K |
| 85007 |
|
1,406 |
1,273 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
526 |
363 |
$1K |
| 82270 |
|
148 |
120 |
$1K |
| 82550 |
|
2,822 |
2,404 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,833 |
2,344 |
$1K |
| 83605 |
|
5,146 |
4,173 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
3,654 |
2,898 |
$1K |
| 73600 |
|
56 |
51 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
2,315 |
1,345 |
$1K |
| 85014 |
|
357 |
312 |
$1K |
| 85651 |
|
705 |
591 |
$1K |
| 43235 |
|
28 |
24 |
$1K |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
583 |
513 |
$1K |
| 80329 |
|
183 |
161 |
$1K |
| 84520 |
|
369 |
310 |
$907.75 |
| 84132 |
|
367 |
274 |
$900.50 |
| 80076 |
|
1,369 |
1,244 |
$893.81 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
66 |
37 |
$862.35 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
38 |
33 |
$819.93 |
| 85018 |
|
331 |
289 |
$783.55 |
| J2785 |
Injection, regadenoson, 0.1 mg |
296 |
238 |
$685.21 |
| 84550 |
|
172 |
145 |
$573.05 |
| J1953 |
Injection, levetiracetam, 10 mg |
46 |
40 |
$553.92 |
| 69209 |
|
16 |
13 |
$550.38 |
| 70498 |
|
69 |
66 |
$520.96 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
548 |
387 |
$506.97 |
| 72040 |
|
14 |
12 |
$388.53 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,837 |
1,583 |
$352.12 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,049 |
977 |
$326.38 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
28 |
24 |
$310.57 |
| 87808 |
|
545 |
519 |
$308.41 |
| 82805 |
|
64 |
55 |
$281.30 |
| 82553 |
|
507 |
397 |
$263.62 |
| J2060 |
Injection, lorazepam, 2 mg |
1,365 |
1,076 |
$238.87 |
| 72170 |
|
18 |
12 |
$235.65 |
| 82150 |
|
1,350 |
1,240 |
$221.40 |
| 72128 |
|
90 |
82 |
$219.68 |
| 82247 |
|
189 |
165 |
$206.81 |
| 74022 |
|
31 |
27 |
$166.12 |
| 72110 |
|
15 |
14 |
$163.88 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,645 |
2,305 |
$146.26 |
| A6251 |
Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
21 |
21 |
$141.82 |
| 84439 |
|
607 |
520 |
$108.70 |
| 82077 |
|
856 |
737 |
$105.45 |
| 84075 |
|
185 |
161 |
$100.76 |
| 82040 |
|
186 |
162 |
$100.76 |
| 84155 |
|
185 |
161 |
$100.76 |
| 84450 |
|
185 |
161 |
$100.76 |
| 84460 |
|
185 |
161 |
$100.76 |
| 82009 |
|
505 |
428 |
$62.27 |
| J0456 |
Injection, azithromycin, 500 mg |
660 |
581 |
$54.46 |
| 86920 |
|
336 |
242 |
$51.83 |
| 88304 |
|
156 |
140 |
$51.40 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
450 |
386 |
$47.39 |
| 82803 |
|
102 |
87 |
$43.23 |
| 87186 |
|
338 |
315 |
$41.73 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
122 |
87 |
$35.78 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
197 |
151 |
$31.98 |
| 86592 |
|
16 |
13 |
$24.14 |
| J1940 |
Injection, furosemide, up to 20 mg |
200 |
117 |
$11.71 |
| 87205 |
|
52 |
45 |
$7.52 |
| 80320 |
|
660 |
573 |
$3.92 |
| J3360 |
Injection, diazepam, up to 5 mg |
92 |
41 |
$0.00 |
| 73660 |
|
44 |
41 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
254 |
194 |
$0.00 |
| 88307 |
|
102 |
87 |
$0.00 |
| 36430 |
|
22 |
12 |
$0.00 |
| 82330 |
|
14 |
14 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
28 |
25 |
$0.00 |
| 73060 |
|
44 |
41 |
$0.00 |
| 87088 |
|
39 |
39 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
13 |
13 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
71 |
61 |
$0.00 |
| 83615 |
|
17 |
14 |
$0.00 |
| 87147 |
|
13 |
13 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
1,146 |
983 |
$0.00 |
| 82248 |
|
47 |
38 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
217 |
160 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
443 |
353 |
$0.00 |
| 85045 |
|
58 |
37 |
$0.00 |
| 70360 |
|
12 |
12 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
931 |
880 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
26 |
12 |
$0.00 |
| S0030 |
Injection, metronidazole, 500 mg |
171 |
147 |
$0.00 |
| 84100 |
|
34 |
28 |
$0.00 |
| 71100 |
|
15 |
13 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
14 |
12 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
46 |
42 |
$0.00 |
| 86677 |
|
12 |
12 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
52 |
42 |
$0.00 |
| S5000 |
Prescription drug, generic |
19 |
19 |
$0.00 |
| 29125 |
|
40 |
38 |
$0.00 |
| 90714 |
|
13 |
13 |
$0.00 |